Loading...
Loading...
Among the 5 tracked institutional investors we monitor, RCEL (AVITA MEDICAL INC) is held with a combined value of $10.96M across 3,060,987 shares. The largest holder is VANGUARD GROUP INC with a position worth $4.98M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 1 fund reduced its position.
Total Institutional Value
$10.96M
Total Shares Held
3,060,987
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $4.98M | 0.00% | New |
| 2 | BlackRock, Inc. | $4.19M | 0.00% | +4.9% |
| 3 | STATE STREET CORP | $1.59M | 0.00% | +2.6% |
| 4 | FMR LLC | $105.95K | 0.00% | +978.6% |
| 5 | CITADEL ADVISORS LLC | $94.81K | 0.00% | -67.3% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of RCEL with a position worth $4.98M, representing 0.00% of their portfolio. In total, 5 institutional investors hold RCEL with a combined value of $10.96M.
In the most recent quarter, 1 fund opened a new position in RCEL. Additionally, 3 increased their holdings and 1 reduced their positions.
Institutional investors hold $10.96M worth of RCEL stock across 5 positions. The largest institutional holder is VANGUARD GROUP INC with $4.98M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For RCEL, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their RCEL positions.